August 8, 2016 |
It's always important to eat wisely, even more so when you're sick. When it comes to cancer, however, researchers are discovering tantalizing new evidence that a patient's diet can actually help shrink tumors. Nicole Simone, a radiation oncologist at Thomas Jefferson University's Sidney Kimmel Cancer Center , has been studying the effect of diet on standard therapies such as radiation and chemotherapy to see whether what you eat can make a difference. So far, it appears that it does.
July 13, 2016 |
The amount of advertising by cancer centers has exploded over the past decade - and so have come-ons that emotionally manipulate or even mislead patients. That is the bottom line of a study and accompanying editorial published Monday in JAMA Internal Medicine. "Cancer center advertisements generally make appeals based on emotion - not fact," wrote Steven Woloshin, a physician and a medical communication researcher with the Dartmouth Institute for Health Policy and Clinical Practice in New Hampshire.
June 12, 2016
Q. Should I get screened for prostate cancer? A. Prostate specific antigen, or PSA, testing remains the main screening test for prostate cancer, along with clinical prostate gland examination. PSA is produced by the prostate gland in men; higher levels of PSA may indicate the presence of prostate cancer. But studies also indicate that overdiagnosis and overtreatment of prostate cancer could be a concern, because men often die with and not of prostate cancer. Because we can't yet determine which early-stage prostate cancers can progress to advanced disease and which are slow-growing and can be left untreated, a number of professional organizations recommend "shared decision-making.
April 30, 2016 |
The Wistar Institute in University City will collaborate with a Swedish biopharmaceutical company, with the goal of developing new cancer therapies. The partnership with Cormorant Pharmaceuticals AB, of Stockholm, will pair Wistar's methods for analyzing tumor biopsies with Cormorant's experimental drug HuMax-IL8, which is in early-stage testing in patients at the National Cancer Institute. Wistar scientist Dmitry I. Gabrilovich and colleagues have developed a new biomarker based on understanding how myeloid suppressor cells play a major role in the regulation of immune responses.
April 11, 2016
2 women in Phila. stabbed, hospitalized Two women who suffered multiple stab wounds were in stable condition Saturday evening at Einstein Medical Center. Police officers from the Fifth District arrived at a home in the 5900 block of Champlost Avenue and found the two women, who were transported to the hospital by city medics, Officer Tanya Little, a police spokeswoman, said. A 31-year-old woman was stabbed in the right knee, right forearm, and left thigh, and had been sprayed with Mace hot-pepper spray.
February 26, 2016 |
HARRISBURG - Gov. Wolf will undergo treatment for what he called a "mild" and treatable form of prostate cancer, but said it would not interfere with his job. In disclosing the illness Wednesday, Wolf, 67, did not offer details about his diagnosis or the treatment he expects in coming months. He said only that it would not require him to step aside, even temporarily. "It really was detected very early. So the procedure is going to be a truly minor one," the governor said at a Capitol news briefing, accompanied only by his wife, Frances.
February 8, 2016 |
Most experts say colon cancer is a multistage disease driven by the accumulation of genetic mutations. Not Scott A. Waldman. The Thomas Jefferson University researcher has spent decades bolstering the iconoclastic idea that colon cancer is basically a hormone-deficiency disease - one that can be reversed or even prevented by restoring the hormone. Now, Waldman's team has also linked that hormone, called guanylin, to obesity, offering a clue to why obese people are at increased risk of colon cancer.
January 11, 2016
Ellen Stovall, 69, a three-time cancer patient nationally known among physicians, legislators and policymakers as one of the country's most forceful advocates for cancer survivors, died Jan. 5 at a hospital in Rockville, Md. Mrs. Stovall's death was announced by the National Coalition for Cancer Survivorship, where she was president and CEO from 1992 to 2008. Her brother, Stephen Lewis, said she had cardiac ailments related to her radiation and chemotherapy. Mrs. Stovall, a Scranton native, was 24 and the mother of a newborn boy when she learned that she had Stage 4 Hodgkin's lymphoma in 1971.
September 17, 2015 |
The Philadelphia-based American Association for Cancer Research trumpeted progress on the disease in a report released Wednesday, noting that nine new cancer drugs were approved by the Food and Drug Administration in the 12 months ending July 31. In that period, one new cancer vaccine and one new cancer screening test were also approved. Six other cancer drugs and one imaging agent were deemed worthy of use in patients with forms of cancer beyond the originally approved use. "Since I started working in the field of oncology about three decades ago, there has been a sea change in our basic understanding of what cancer is," José Baselga, AACR president, said in the report.
September 15, 2015 |
Psychologist Caryn Lerman spent decades studying how people react when they learn their behavior has put them at high risk of developing cancer. But education, she saw early on, isn't enough to help some smokers kick the habit. "The motivation to quit became stronger and they tried to quit more times, but they actually were unable to," said Lerman, who is now senior deputy director of the University of Pennsylvania's Abramson Cancer Center. "I then became very interested in why it was so hard to quit smoking.